CRO - Services pharmaceutical, biotechnology and medical devices companies, scientific societies.

Home

Contact

Links

English

Spanish

Your partner in Spain |

Work with us |

Customers |

Contact

Customers

We are currently working with multinational pharmaceutical companies, multinational CROs, medical institutions, scientific societies and medical associations.

Click the link to see the Scientific Papers by Drug Solutions.

Below are the therapeutic areas in which we have been involved so far.

Cardiovascular
· Hypertension	Phase 4
· Unstable angina	Phase 4
· Percutaneous coronary intervention	Phase 3
· Heart attack	Phase 2
· Marfan syndrome	Phase 4
Infectious Diseases
· Intra-abdominal infections	Phase 3
· Invasive Aspergillus infections	Phase 3
· Neutropenic fever	Phase 2
· Invasive candidiasis	Phase 2
Oncology
· Prevention of chemotherapy-induced nausea	Phase 3
· Prostate cancer	Phase 2
· Lung cancer	Phase 3
Autoimmune Diseases
· Rheumatoid arthritis (2 Clinical Trials)	Phase 2
· Systemic lupus erythematosus	Phase 2
Neurology
· Parkinson’s disease (3 Clinical Trials)	Phase 2, 3 and 4
· Restless legs syndrome (2 Clinical Trials)	Phase 3
· Multiple sclerosis	Phase 3
Nursery
· Use of catheters	Phase 4

1.- G. Linazasoro, J. Kulisevskyb, B. Hernández and on behalf of the Spanish Stalevo Study Group*
“Should levodopa dose be reduced when switched to stalevo?”
European Journal of Neurology 2008, 15: 257–261

2.- Juan Luis González López, Encarnación Ferenández del Palacio, Carmen Benedicto Marti, Javier Olivares Corral, Pilar Herrera Portal, Ana Arribi Vilela
“COSMOS – a study comparing peripheral intravenous systems”.
British Journal of Nursing, 2009, Vol 18, No 14 (844-853)

3.- Diego García-Borreguero, Oscar Larrosa, Anne-Marie Williams, Javier Albares, Mireia Pascual, José Carlos Palacios, Cristina Fernández.
“Treatment of restless legs syndrome with pregabalin: A double-blind, placebo-controlled study”
MS ID# NEUROLOGY/2009/299651. In press.

4.- Some publications under development.

Terms and conditions of use

Intellectual property rights www.Drugsolutions.es portal and various elements contained therein are owned by Drugsolutions.es.

Drugsolutions.es reserves the right to make, at any time and without prior notice, modify and update the information contained on the website or its configuration or presentation.

Drugsolutions.es not guarantee the absence of errors in accessing the site or its contents or that it is completely updated.

The unauthorized use of the information contained in this web site as well as the damages and losses caused to the intellectual property rights and industrial Drugsolutions.es, will result in pursuit of legal actions that correspond to that authority and, where appropriate , to the responsibilities arising from this exercise.

Both access to the website and the use made of the information contained herein are solely the responsibility of the user. Drugsolutions.es not responsible for any consequence or damage that may arise from such access or use of information, with the exception of any actions resulting from the application of laws to which it is subject to the strict exercise of its powers.

Drugsolutions.es assumes no liability whatsoever arising from the connection or the content of linked third party that may contain the portal. Recognizes that the rights of intellectual property of the linked pages belong to their respective authors and owners and the request of either the link or links will be removed immediately.